1. Thorsett ED, Harris EE, Aster SD, Peterson ER, Snyder JP, Springer JP, Hirshfield J, Tristram EW, Patchett AA, Ulm EH.. (1986) Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations., 29 (2): [PMID:3005569] [10.1021/jm00152a014] |
2. Gomez-Monterrey, I I, Beaumont, A A, Nemecek, P P, Roques, B P BP and Fournie-Zaluski, M C MC. 1994-06-10 New thiol inhibitors of neutral endopeptidase EC 3.4.24.11: synthesis and enzyme active-site recognition. [PMID:8021926] |
3. Michaud, A A, Williams, T A TA, Chauvet, M T MT and Corvol, P P. 1997-06 Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I. [PMID:9187274] |
4. Lefebvre, H P HP and 5 more authors. 2007 Angiotensin-converting enzyme inhibitors in veterinary medicine. [PMID:17506720] |
5. Robinson, Dean M DM, Curran, Monique P MP and Lyseng-Williamson, Katherine A KA. 2007 Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure. [PMID:17547476] |
6. Ceconi, Claudio C and 5 more authors. 2007-12-22 Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. [PMID:17716647] |
7. Deaton, David N and 5 more authors. 2008-01-15 Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite. [PMID:18078750] |
8. Deaton, David N; Graham, Kevin P; Gross, Jeffrey W and Miller, Aaron B. 2008-03-01 Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite. [PMID:18243695] |
9. Grice, Cheryl A CA and 15 more authors. 2008-07-24 Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. [PMID:18588282] |
10. Madsen, Julie L H JL and 5 more authors. 2012-09-13 Synthesis and evaluation of silanediols as highly selective uncompetitive inhibitors of human neutrophil elastase. [PMID:22882079] |
11. Day, Joshua A and Cohen, Seth M. 2013-10-24 Investigating the selectivity of metalloenzyme inhibitors. [PMID:24074025] |
12. Charton, Julie J and 16 more authors. 2014-05-22 Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis. [PMID:24735644] |
13. Sattigeri, Jitendra A JA and 20 more authors. 2017-06-01 Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome. [PMID:28442252] |
14. Manikandan, A A, Moharil, Pearl P, Sathishkumar, M M, Muñoz-Garay, C C and Sivakumar, A A. 2017-12-01 Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential. [PMID:29032034] |
15. McKinnell, R Murray RM and 13 more authors. 2019-01-10 Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI). [PMID:30655952] |
16. Sharma, Urvashi; Cozier, Gyles E; Sturrock, Edward D and Acharya, K Ravi. 2020-05-28 Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme. [PMID:32337993] |